Search
Fudan University's Huashan Hospital and Beijing Xuanwu Hospital are spearheading a clinical cohort study on brain-computer interfaces (BCIs), having commenced patient enrollment to ascertain the efficacy and safety of implantable BCI treatments. Additionally, Shanghai is poised to establish a dedicated sub-association for BCIs and neuromodulation, fostering "industry-university-research-medicine" collaboration in this burgeoning field. 2025 is envisioned as a pivotal year for China's BCI technology to transition into clinical practice, with Beijing, Shanghai, and other cities aiming to conclude clinical trials for over five invasive BCI products by 2030. These milestones underscore the rapid evolution and persistent advancement of clinical applications within China's BCI technology landscape.
-
C114 Communication Network -
Communication Home
